Trials / Completed
CompletedNCT07313137
Antiplatelet Use in Dementia Subtypes
Antiplatelet Use in All-Cause Dementia and Dementia Subtypes Among Older Adults: A Population-Based Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 683 (actual)
- Sponsor
- Gulhane Training and Research Hospital · Other Government
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This population-based retrospective cohort study aimed to evaluate the appropriateness of antiplatelet therapy use among older adults with all-cause dementia and across different dementia subtypes. Medical records of patients aged 65 years and older who were evaluated at a tertiary-level geriatric outpatient clinic were reviewed. Dementia subtypes were classified according to internationally accepted diagnostic criteria. Patterns of antiplatelet use were assessed in accordance with current guideline recommendations. The study sought to determine the appropriateness of antiplatelet use across dementia subtypes and to describe real-world prescribing practices in this population.
Conditions
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2025-12-31
- Last updated
- 2025-12-31
Source: ClinicalTrials.gov record NCT07313137. Inclusion in this directory is not an endorsement.